- Home
- JGH vs CYRX Comparison
JGH vs CYRX Comparison
Compare JGH & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JGH
- CYRX
- Stock Information
- Founded
- JGH 2014
- CYRX 1999
- Country
- JGH United States
- CYRX United States
- Employees
- JGH N/A
- CYRX N/A
- Industry
- JGH Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- JGH Finance
- CYRX Health Care
- Exchange
- JGH Nasdaq
- CYRX Nasdaq
- Market Cap
- JGH 296.7M
- CYRX 310.4M
- IPO Year
- JGH N/A
- CYRX N/A
- Fundamental
- Price
- JGH $13.00
- CYRX $6.09
- Analyst Decision
- JGH
- CYRX Strong Buy
- Analyst Count
- JGH 0
- CYRX 6
- Target Price
- JGH N/A
- CYRX $11.50
- AVG Volume (30 Days)
- JGH 73.9K
- CYRX 663.5K
- Earning Date
- JGH 01-01-0001
- CYRX 05-06-2025
- Dividend Yield
- JGH 9.85%
- CYRX N/A
- EPS Growth
- JGH N/A
- CYRX N/A
- EPS
- JGH N/A
- CYRX N/A
- Revenue
- JGH N/A
- CYRX $228,385,000.00
- Revenue This Year
- JGH N/A
- CYRX $9.18
- Revenue Next Year
- JGH N/A
- CYRX $8.65
- P/E Ratio
- JGH N/A
- CYRX N/A
- Revenue Growth
- JGH N/A
- CYRX N/A
- 52 Week Low
- JGH $10.36
- CYRX $4.58
- 52 Week High
- JGH $12.85
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- JGH 47.83
- CYRX 47.99
- Support Level
- JGH $12.86
- CYRX $5.90
- Resistance Level
- JGH $13.08
- CYRX $7.00
- Average True Range (ATR)
- JGH 0.12
- CYRX 0.61
- MACD
- JGH 0.02
- CYRX 0.03
- Stochastic Oscillator
- JGH 67.12
- CYRX 35.88
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.